Replicase cycling reaction (RCR)
OwnerShi-Lung Lin, Sam Lin +1inventors
InventorsShi-Lung Lin, Sam Lin, Chun-Hung Lin
Life of this patent
Estimating the term…
Loading patent…
OwnerShi-Lung Lin, Sam Lin +1inventors
InventorsShi-Lung Lin, Sam Lin, Chun-Hung Lin
Estimating the term…
This invention generally relates to a novel RNA/mRNA production and amplification method using viral RNA replicase and/or RNA-dependent RNA polymerase (RdRp) enzymes as well as the associated mRNAs thereof. The present invention can be used for manufacturing and amplifying all varieties of RNA/mRNA sequences carrying at least an RdRp-binding site in the 5′- or 3′-end, or both. The RNA/mRNA so obtained is useful for not only producing mRNA vaccines and/or RNA-based medicines but also for generating the mRNA-associated proteins, peptides, and/or antibodies under an in-vitro as well as in-cell translation condition. Principally, the present invention is a novel RNA replicase-mediated RNA/mRNA amplification method, namely Replicase Cycling Reaction (RCR). The RNA replicases involved in RCR include but not limited to viral and/or bacteriophage RNA-dependent RNA polymerases (RdRp), particularly coronaviral and hepatitis C viral (HCV) RdRp enzymes.
An RNA replicase-mediated RNA amplification method, comprising:
Dependencies are inferred from the claim text.